Vol 27, No 2 (2022)
Technical note
Published online: 2022-03-17

open access

Page views 4696
Article views/downloads 309
Get Citation

Connect on Social Media

Connect on Social Media

Vas deferens metastasis from prostate adenocarcinoma treated with daily-adaptive MR-guided SBRT on 1.5T MR-linac

Claudio Vitale1, Luca Nicosia1, Edoardo Pastorello1, Michele Rigo1, Joniada Doraku2, Matteo Salgarello2, Filippo Alongi13
Rep Pract Oncol Radiother 2022;27(2):371-374.



Article available in PDF format

View PDF Download PDF file


  1. Sciarra A, Panebianco V, Salciccia S, et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol. 2008; 54(3): 589–600.
  2. Freitag MT, Radtke JP, Afshar-Oromieh A, et al. Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI. Eur J Nucl Med Mol Imaging. 2017; 44(5): 776–787.
  3. Mazzola R, Francolini G, Triggiani L, et al. Metastasis-directed Therapy (SBRT) Guided by PET-CT F-CHOLINE Versus PET-CT Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness. Clin Genitourin Cancer. 2021; 19(3): 230–236.
  4. Yigit N, Karslioglu Y, Kurt B. Vas deferens invasion: A neglected issue in the sampling of radical prostatectomy materials. Can Urol Assoc J. 2014; 8(7-8): E554–E557.
  5. Nicosia L, Sicignano G, Rigo M, et al. Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy. Acta Oncol. 2021; 60(2): 215–221.
  6. Ruggieri R, Rigo M, Naccarato S, et al. Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time. Phys Med. 2020; 80: 34–41.
  7. Cuccia F, Rigo M, Gurrera D, et al. Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases. J Cancer Res Clin Oncol. 2021; 147(11): 3269–3277.
  8. Valle LG, Rahal A, Falsarella PM, et al. Prostate cancer recurrence in vas deferens - fusion image guide as an important tool in dignosis. Int Braz J Urol. 2018; 44(1): 192–195.
  9. Priftakis D, Afaq A, Bomanji J. Imaging of Prostate Cancer Recurrence in the Vas Deferens With 68Ga-PSMA PET/CT. Clin Nucl Med. 2020; 45(1): 49–51.
  10. Mazzola R, Figlia V, Rigo M, et al. Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes. J Cancer Res Clin Oncol. 2020; 146(9): 2379–2397.

Reports of Practical Oncology and Radiotherapy